Skip to main content
Market intelligence
BRVESector not reported

Braveheart Bio, Inc. insider activity

In the last 90 days, 18 corporate insiders purchased $482,674,950 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
3
90-day purchase value
$482,674,950
Corporate buyers
18
Latest transaction
Aug 7, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 7, 2026James Paul RickeyChief Financial OfficerOpen Market Purchase27,777$18.00$499,986
Aug 7, 2026Christopher ViehbacherCorporate insiderOpen Market Purchase83,333$18.00$1,499,994
Aug 7, 2026David I MalekCorporate insiderOpen Market Purchase4,166$18.00$74,988